Trademark Search in Canada

SAGASAFE

View On IC.GC.CA

REGISTERED

on 1 Mar 2023

Last Applicant/ Owned by

SAGA DIAGNOSTICS AB

Medicon Village,Scheelevägen 2SE-223 81 Lund

Serial Number

2057421 filed on 5^th Mar 2020

Registration Number

TMA1168283 registered on 1^st Mar 2023

Registration expiry Date

5^th Mar 2030

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

M5H3Y2

SAGASAFE

Trademark usage description

biological preparations for the treatment of cancer; botanicals for the treatment of cancer; herbal supplements for the treatment of cancer; herbal pi Read More

Classification Information

Class [005]
Biological preparations for the treatment of cancer; botanicals for the treatment of cancer; herbal supplements for the treatment of cancer; herbal pills for the treatment of cancer; biological reagents for veterinary use; medicinal preparations for use in oncology; pharmaceutical antibody preparations for the treatment of cancer; anti-cancer preparations; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of cancer; chemical preparations for the diagnosis of pregnancy; radioactive pharmaceutical preparations for in vivo diagnostics or therapeutic use; pregnancy testing preparations; preparations for use in the diagnosis of pregnancy; diagnostic reagents for veterinary purposes; diagnostic test reagents for veterinary purposes; reagents for use in veterinary genetic testing; nucleic acid sequences in the form of oligonucleotides for diagnosing and monitoring cancer; reagents for use in medical genetic testing; reagents for use in veterinary genetic testing; chemical preparations for testing blood for medical purposes; chemical preparations for the diagnosis of pregnancy; chemical preparations for use in dna analysis [medical]; clinical diagnostic reagents; diagnostic chemical reagents for medical purposes; diagnostic reagents for medical purposes; diagnostic test reagents for medical purposes; reagents for use in diagnostic pregnancy tests for medical purposes; reagents for use in diagnostic tests for medical purposes; reagent paper for medical and veterinary purposes; reagents for use in diagnostic pregnancy tests for veterinary purposes; reagents for use in diagnostic tests for veterinary purposes; genetic identity tests comprised of reagents for medical purposes; drug testing kits comprising primarily medical diagnostic reagents and assays for testing body fluids; genetic identity tests comprised of reagents for medical purposes; medical diagnostic reagents and assays for testing of body fluids; diagnostic agents for medical use; diagnostic biomarker reagents for medical purposes; diagnostic chemical reagents for medical use; diagnostic agents for medical use in in vivo scanning; diagnostic biomarker reagents for medical purposes; diagnostic biomarkers for use in assessment of genomic analysis for medical use; diagnostic preparations for medical laboratory use; diagnostic preparations for medical purposes for detecting genetic predispositions; diagnostic preparations for medical purposes for detecting mutation in prion genes; diagnostic reagents for medical diagnostic use; diagnostic reagents for medical laboratory use; diagnostic preparations for clinical laboratory use; diagnostic preparations for medical laboratory use; medical diagnostic reagents and assays for testing of body fluid; diagnostic reagents for medical use; diagnostic test reagents for medical purposes; diagnostic preparations for in vitro testing for medical use; diagnostic biomarkers for in vitro testing for medical use; genetic identity tests comprised of reagents for medical purposes; indicators for medical diagnosis, namely circulating biomarkers for use in detection of circulating tumor DNA and circulating RNA in body fluids for diagnosing and monitoring cancer; medical diagnostic reagents and assays for testing of body fluids; diagnostic strips for measuring circulating tumor DNA levels in body fluids for diagnosing and monitoring cancer; preparations for detecting genetic predispositions for medical purposes; preparations for detecting mutation in prion genes for medical purposes; reagents for blood grouping [for medical purposes]; in vitro diagnostic preparations for medical purposes; in vitro diagnostic preparations for veterinary purposes; reagents for use in diagnostic tests [for medical purposes]; reagents for use in diagnostic tests [for veterinary purposes]; reagents for use in diagnostic pregnancy tests; veterinary diagnostic reagents.

Classification kind code

Class [042]
Analysis of human serum for medical research; analysis of human tissues for medical research; biological research, clinical research and medical research; clinical research; clinical trials; conducting early evaluations in the field of new pharmaceuticals; consulting in the field of clinical trials for pharmaceutical products; consultancy relating to pharmaceutical research and development; medical research; medical research laboratory services; pharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical research and development; providing information about the results of clinical trials for pharmaceutical products; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing scientific information in the field of medical disorders and their treatment; provision of information and data relating to medical and veterinary research and development; research and development for the pharmaceutical industry; research and development in the field of biochemistry and biotechnology; biochemical research; research and development of vaccines and medicines; scientific research in the field of genetics and genetic engineering; scientific research for medical purposes in the area of cancerous diseases; services for assessing the efficiency of pharmaceuticals; services for assessing the efficiency of veterinary drugs.

Classification kind code

Class [044]
Genetic counseling; genetic testing of animals for diagnostic or treatment purposes; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; conducting of medical examinations; health care services for treating cancer; providing cancer screening services; drug screening for medical purposes; medical clinic services; medical treatment using cultured cells; medical diagnostic testing, monitoring and reporting services; stem cell therapy services; analysis of human serum for medical treatment; analysis of human tissues for medical treatment; blood bank services; bowel cancer screening services; breast cancer screening services; cervical cancer screening services; colonoscopy screening services; counselling regarding the choice of medication, drug usage and information on side effects; DNA screening for medical purposes; genetic testing for medical purposes; hepatitis screening services; lung cancer screening services; medical advice in the field of pregnancy; medical analysis for the diagnosis and treatment of persons; medical analysis services for cancer diagnosis and prognosis; medical analysis services for the diagnosis of cancer; medical analysis services relating to the treatment of patients; medical analysis services relating to the treatment of persons; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical analysis services relating to the treatment of persons provided by a medical laboratory; RNA or DNA analysis for cancer diagnosis, monitoring and prognosis; medical care and analysis services relating to patient treatment; genetic counselling; pharmaceutical consultancy services; professional consultancy in the field of medical technology; medical diagnostic services; medical laboratory services for the analysis of blood samples taken from patients; medical laboratory services for the analysis of samples taken from patients; medical screening; medical services for the treatment of skin cancer; medical services in the field of oncology; medical testing for diagnostic or treatment purposes; medical testing services relating to the diagnosis and treatment of disease; prostate cancer screening services; providing cancer screening services; RNA or DNA analysis for cancer diagnosis and prognosis; services for the testing of blood; services for the testing of sera; services for the testing of urine; services for the preparation of medical reports; testicular cancer screening services.

Classification kind code

Mark Details

Serial Number

2057421

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 48 on 31^st Jan 2022	Agent Changed
Submitted for opposition 22 on 18^th Oct 2021	Search Recorded
Submitted for opposition 20 on 18^th Oct 2021	Examiner's First Report
Submitted for opposition 223 on 18^th Oct 2021	Total Provisional Refusal
Submitted for opposition 256 on 16^th Aug 2021	Notification of Possible Opposition Sent
Submitted for opposition 257 on 15^th Oct 2020	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 14^th Oct 2020	Created
Submitted for opposition 31 on 14^th Oct 2020	Formalized
Submitted for opposition 30 on 5^th Mar 2020	Filed
Submitted for opposition 228 on 5^th Mar 2020	International Registration